(CD5E) Amundi Index Solutions - Ratings and Ratios
European Stocks, Index Funds, Large Cap Stocks
Description: CD5E Amundi Index Solutions
The Amundi EURO STOXX50 UCITS ETF-D EUR is an exchange-traded fund (ETF) designed to replicate the performance of the EURO STOXX50 Index, a benchmark comprising the 50 largest and most liquid stocks in the Eurozone. The funds primary objective is to minimize the tracking error between its net asset value and the indexs performance.
With Assets Under Management (AUM) of approximately 793.83 million EUR, this ETF is a sizable player in the Eurozone Large-Cap Equity category. Its liquidity and trading volume can be inferred from its listing on the Swiss market, with a ticker symbol of CD5E.
From a performance perspective, the ETF has demonstrated a strong upward trend, with its current price of 85.82 EUR being close to its 52-week high of 88.00 EUR. The funds short-term moving averages (SMA20 and SMA50) are in close proximity, indicating a stable short-term outlook. The longer-term SMA200 is significantly lower, suggesting a strong uptrend over the past year. The Average True Range (ATR) of 0.53 EUR, or 0.62%, indicates relatively moderate volatility.
Key Performance Indicators (KPIs) for this ETF include its tracking error, which is crucial in evaluating its ability to replicate the EURO STOXX50 Index. Other relevant KPIs include its expense ratio, trading volume, and bid-ask spread, which can impact its overall cost and liquidity. As a Trading Analyst, it is essential to monitor these KPIs to ensure that the ETF remains an optimal investment choice.
To further evaluate this ETF, one could analyze its sector and stock holdings to understand its underlying composition and potential risks. Additionally, comparing its performance and KPIs to those of similar ETFs in the Eurozone Large-Cap Equity category can provide valuable insights into its relative strengths and weaknesses.
Additional Sources for CD5E ETF
CD5E ETF Overview
Market Cap in USD | 927m |
Category | Eurozone Large-Cap Equity |
TER | 0.09% |
IPO / Inception | 2018-02-14 |
CD5E ETF Ratings
Growth Rating | 48.8 |
Fundamental | - |
Dividend Rating | 52.8 |
Rel. Strength | -0.81 |
Analysts | - |
Fair Price Momentum | 86.57 EUR |
Fair Price DCF | - |
CD5E Dividends
Dividend Yield 12m | 2.69% |
Yield on Cost 5y | 4.34% |
Annual Growth 5y | 4.40% |
Payout Consistency | 100.0% |
Payout Ratio | % |
CD5E Growth Ratios
Growth Correlation 3m | 51.1% |
Growth Correlation 12m | 91% |
Growth Correlation 5y | 91% |
CAGR 5y | 74.08% |
CAGR/Max DD 5y | 3.31 |
Sharpe Ratio 12m | 0.86 |
Alpha | 64.72 |
Beta | 0.558 |
Volatility | 15.83% |
Current Volume | 7.1k |
Average Volume 20d | 0.9k |
Stop Loss | 84.7 (-3.5%) |
As of July 15, 2025, the stock is trading at EUR 87.80 with a total of 7,111 shares traded.
Over the past week, the price has changed by +1.94%, over one month by +2.91%, over three months by +13.28% and over the past year by +13.99%.
Partly, yes. Based on ValueRay´s Analyses, Amundi Index Solutions (SW:CD5E) is currently (July 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 48.81 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CD5E is around 86.57 EUR . This means that CD5E is currently overvalued and has a potential downside of -1.4%.
Amundi Index Solutions has no consensus analysts rating.
According to our own proprietary Forecast Model, CD5E Amundi Index Solutions will be worth about 97.8 in July 2026. The stock is currently trading at 87.80. This means that the stock has a potential upside of +11.33%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 97.8 | 11.3% |